Homburger advised UBS Switzerland on the issuance, under the bank’s covered bond programme, of fixed rate covered bonds in the aggregate amount of CHF 685 million. Governed by Swiss law and listed on SIX Swiss
Tags :Homburger
Homburger advised Zürcher Kantonalbank (ZKB) on the issuance of € 500 million 2.950 per cent. fixed rate bonds due January 26, 2031. The senior unsecured bonds in question have been issued under Zürcher Kantonalbank’s Swiss base prospectus.
Homburger advised Fastned Tico Holding I B.V., a direct subsidiary of electric fast-charging stations operator Fastned B.V., in connection with its role as borrower in a Dutch law-governed EUR 100 m committed senior multicurrency
Homburger advised Raiffeisen Schweiz Genossenschaft in connection with its role — together Basler Kantonalbank — as joint lead manager on the CHF 100 million green bonds issuance by HIAG Immobilien Holding, a Swiss real estate company with headquarters
Homburger advised UBS Group on a of EUR 3 notes issuance under the bank’s senior debt programme. The operation includes two tranches of EUR 1.5 bn each, respectively due February 2031 and January 2037. The notes in question
Homburger advised Baseline Wealth Management, a wealth management specialist with headquarters in Zurich and Geneva, in connection with the company’s sale to US-based Creative Planning. The Homburger team Frank Gerhard (corporate/M&A,
Homburger advised UBS Group on tier 1 capital notes, for an aggregate value of USD 3 bn. The notes in question are high-trigger regulatory capital instruments eligible under UBS Group’s Swiss going-concern requirements, governed by Swiss
Homburger advised 21Shares on the completion of a merger by absorption, pursuant to which FalconX, acquired 21Shares’ ultimate parent company. The transaction was completed in November 2025. Following the merger, 21Shares continues to operate as an
With the start of the new year, Homburger formalised the appointment of three new partners: Reto Ferrari-Visca (pictured centre), Jeremy Reichlin (pictured left), and Alexander Wherlock (pictured right). Reto Ferrari-Visca Reto Ferrari-Visca represents clients across
Homburger advised Windward Bio Group — a Swiss-based biotechnology specialist in advanced immunological diseases — in connection with a licensing agreement between the company’s affiliate, LE2025 Therapeutics, and Qyuns Therapeutics Co. for the development
